Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
10.45
+0.09 (0.87%)
At close: Sep 17, 2025, 4:00 PM EDT
10.65
+0.20 (1.91%)
After-hours: Sep 17, 2025, 7:08 PM EDT
Organon & Co. Market Cap
Organon & Co. has a market cap or net worth of $2.72 billion as of September 17, 2025. Its market cap has decreased by -52.71% in one year.
Market Cap
2.72B
Enterprise Value
11.01B
1-Year Change
-52.71%
Ranking
Category
Stock Price
$10.45
Market Cap Chart
Since May 14, 2021, Organon & Co.'s market cap has decreased from $8.42B to $2.72B, a decrease of -67.72%. That is a compound annual growth rate of -22.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 2.69B | -29.91% |
| Dec 31, 2024 | 3.84B | 4.25% |
| Dec 29, 2023 | 3.69B | -48.12% |
| Dec 30, 2022 | 7.10B | -7.98% |
| Dec 31, 2021 | 7.72B | -8.27% |
| May 14, 2021 | 8.42B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |